A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection

Journal of Glaucoma

Volumn 17, Issue 2, 2008, Pages 128-132

  Im, Lily ^a,c   Allingham, R Rand ^b   Singh, Inder ^b   Stinnett, Sandra ^b   Fekrat, Sharon ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c NONE   (United States)

Author keywords

Gonioscopy; Intraocular pressure; Intravitreal Kenalog; Steroid response

Indexed keywords

ACETAZOLAMIDE; TRIAMCINOLONE ACETONIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLAUCOMA; GONIOSCOPY; HUMAN; INTRAOCULAR PRESSURE; MALE; MONOTHERAPY; MYOPIA; OCULAR HISTOPLASMOSIS; OPTIC NERVE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA EDEMA; RETINA VEIN OCCLUSION; RISK FACTOR; SUBRETINAL NEOVASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CHOROIDAL NEOVASCULARIZATION; FEMALE; GLUCOCORTICOIDS; GONIOSCOPY; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; MACULAR DEGENERATION; MACULAR EDEMA; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 40949161371     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31814b9948     Document Type: Article

References (24)

1. Machemer R, Sugita G, Tano Y. Treatment of intraocular proliferations with intravitreal steroids. Trans Am Ophthalmol Soc. 1979;77:171-180.
2. Jonas J, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for the treatment of intraocular proliferative, exudative and neovascular diseases. Prog Retin Eye Res. 2005;24:587-611.
3. Massin P, Audren F, Haouchine B, et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema. Ophthalmology. 2004;111:218-224.
4. Young S, Larkin G, Branley M, et al. Safety and efficacy of intravitreal triamcinolone for cystoid macular oedmea in uveitis. Clin Experiment Ophthalmol. 2001;29:2-6.
5. Park CH, Jaffe GJ, Fekrat S. Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central renal vein occlusion. Am J Ophthalmol. 2003;136:419-425.
6. Challa JK, Gillies MC, Penfold PL, et al. Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up. Aust N Z J Ophthalmol. 1998;26:277-281.
7. Ozkiris A, Everklioglu C, Erkilic K, et al. Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema. Eur J Ophthalmol. 2004;14:543-549.
8. Gillies MC, Simpson JM, billson FA, et al. Safety of an intravitreal injection of triamcinolone. Arch Ophthalmol. 2004;122:336-340.
9. Gillies MC, Kuzniarz M, Craig J, et al. Intravitreal triamcinolone- induced elevated intraocular pressure is associated with the development of posterior subcapsular cataract. Ophthalmology. 2005;112:139-143.
10. Ozkiris A, Erkilic K. Complications of intravitreal injection of triamcinolone acetonide. Can J Ophthalmol. 2005;40:63-68.
11. Kaushik S, Gupta V, Gupta A, et al. Intractable glaucoma following intravitreal triamcinolone in central retinal vein occlusion. Am J Ophthalmol. 2004;137:758-760.
12. Smithen LM, Ober MD, Maranan L, et al. Intravitreal triamcinolone acetonide and intraocular pressure. Am J Ophthalmol. 2004;138:740-743.
13. Jonas J, Degenring R, Dreissig I, et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology. 2005;112:593-598.
14. Jonas J, Dengenring R, Kamppeter B, et al. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol. 2004;138:158-160.
15. Jonas J, Spandau U, Kamppeter B, et al. Follow-up after intravitreal triamcinolone acetonide for diabetic macular edema. Eur J Ophthalmol. 2006;16:566-572.
16. Rhee DJ, Peck RE, Belmont J, et al. Intraocular pressure alterations following intravitreal triamcinolone acetonide. Br J Ophthalmol. 2006;90:999-1003.
17. Lee E, Jariprasad S, Mieler W, et al. Short-term intraocular pressure trends after intravitreal triamcinolone injection. Am J Ophthalmol. 2007;143:365-367.
18. Jonas J, Heatley G, Spaid R, et al. Intravitreal triamcinolone acetonide and secondary ocular hypertension. J Glaucoma. 2005;14:168-171.
19. Park HY, Yi K, Kim HK. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Korean J Ophthalmol. 2005;19:122-127.
20. Singh IP, Ahmad SI, Yeh D, et al. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol. 2004;138:286-287.
21. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina. 2005;25:685-690.
22. Androudi S, Letko E, Meniconi M, et al. Safety and efficacy of intravitreal triamcinolone acetonide for uveitic macular edema. Ocul Immunol Inflamm. 2005;13:205-212.
23. Bakri SJ, Beer PM. The effect of intravitreal triamcinolone acetonide on intraocular pressure. Ophthalmic Surg Lasers Imaging. 2003;34:386-390.
24. Yang C, Chen M, Chou C, et al. Refractor severe ocular hypertension after intravitreal triamcinolone acetonide injection. Ophthalmologica. 2005;219:413-415.